Computer aided drug design based on 3D-QSAR and molecular docking studies of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives as PIM2 inhibitors: a proposal to chemists
- 8 Downloads
PIM2 kinase plays a crucial role in the cell cycle events including survival, proliferation, and differentiation in normal and neoplastic neuronal cells. Thus, it is regarded as an essential target for cancer pharmaceutical. Design of novel 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives with enhanced PIM2 inhibitory activity. A series of twenty-five PIM2 inhibitors reported in the literature containing 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines scaffold was studied by using two computational techniques, namely, three-dimensional quantitative structure activity relationship (3D-QSAR) and molecular docking. The comparative molecular field analysis (CoMFA) and comparative molecular similarity indexes analysis (CoMSIA) studies were developed using nineteen molecules having pIC50 ranging from 8.222 to 4.157. The best generated CoMFA and CoMSIA models exhibit conventional determination coefficients R2 of 0.91 and 0.90 as well as the Leave One Out cross-validation determination coefficients Q2 of 0.68 and 0.62, respectively. Moreover, the predictive ability of those models was evaluated by the external validation using a test set of six compounds with predicted determination coefficients R test 2 of 0.96 and 0.96, respectively. Besides, y-randomization test was also performed to validate our 3D-QSAR models. The most and the least active compounds were docked into the active site of the protein (PDB ID: 4 × 7q) to confirm those obtained results from 3D-QSAR models and elucidate the binding mode between this kind of compounds and the PIM2 enzyme. These satisfactory results are not offered help only to understand the binding mode of 5-(1H-indol-5-yl)-1,3,4-thiadiazol series compounds into this kind of targets, but provide information to design new potent PIM2 inhibitors.
KeywordsCoMFA CoMSIA Molecular docking PIM2 Drug design 5-(1H-indol-5-yl)-1,3,4-thiadiazol
We are grateful to the “Association Marocaine des Chimistes Théoriciens” (AMCT) and “Moroccan centre of scientific and technique research” (CNRST) for their pertinent help concerning the programs.
Compliance with ethical standards
The authors declare that they have no competing interests.
- Brault L, Gasser C, Bracher F, Huber K, Knapp S, Schwaller J (2010) PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica [Internet] 95(6):1004–1015. Available from: http://www.haematologica.org/cgi/doi/10.3324/haematol.2009.017079
- Clark M, Cramer RD, Van Opdenbosch N (1989) Validation of the general purpose tripos 5.2 force field. J Comput Chem [Internet] 10(8):982–1012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12192139
- Dassault Systèmes BIOVIA, Discovery Studio Modeling Environment, Release 2017, San Diego: Dassault Systèmes. [Internet]. [cited 2017 Feb 25]. Available from: http://accelrys.com/products/collaborative-science/biovia-discovery-studio/
- Golbraikh A, Tropsha A (2002) Beware of q2! J. Mol. Graph. Model [Internet] 20(4):269–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11858635
- Gupta SP, Mathur AN, Nagappa AN, Kumar D, Kumaran S (2003) A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[(4-(aminoalkoxy)phenyl)sulphonyl]indolizines. Eur J Med Chem [Internet]. 38(10):867–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14575933
- Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337–41. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1740674904000551
- Nawijn MC, Alendar A, Berns A (2011a) For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer Nature Publishing Group 11(1):23–34. Available from: http://www.nature.com/nrc/journal/v11/n1/pdf/nrc2986.pdf%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/21150935
- Santio NM, Vahakoski RL, Rainio E-M, Sandholm JA, Virtanen SS, Prudhomme M et al (2010) Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion. Mol Cancer 9(1):279. https://doi.org/10.1186/1476-4598-9-279 CrossRefPubMedCentralPubMedGoogle Scholar
- Ståhle L, Wold S (1988) Multivariate data analysis and experimental design in biomedical research. Prog Med Chem 25:291–338. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3076969
- SYBYL-X 2.0 [Internet]. St. Louis, MO, USA: Tripos Inc; Available from: http://www.tripos.com
- Zheng J, Xiao G, Guo J, Zheng Y, Gao H, Zhao S et al (2011) Exploring QSARs for 5-Lipoxygenase (5-LO) Inhibitory Activity of 2-Substituted 5-Hydroxyindole-3-Carboxylates by CoMFA and CoMSIA. Chem Biol Drug Des 78(2):314–321. https://doi.org/10.1111/j.1747-0285.2011.01146.x CrossRefPubMedGoogle Scholar